Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Badger Reformulating Sunscreens For Babies, Kids As Recall Unfolds

This article was originally published in The Tan Sheet

Executive Summary

Testing shows the products are contaminated with potentially infectious microorganisms: Pseudomonas aeruginosa, Candida parapsilosis and Acremonium fungi. Badger says it is moving to a different contract manufacturer “to eliminate any processing factors that may have contributed to this situation.”

You may also be interested in...



EWG Supports Nano-Engineered Mineral Sunscreens In 2013 Report

Sunscreens containing zinc oxide and titanium dioxide nanoparticles rate relatively highly in the Environmental Working Group’s annual Sunscreen Guide, though the advocacy group says greater transparency is needed regarding products with nano-engineered ingredients.

“Extremist” Groups Needlessly Alarm Consumers About Cosmetics – Report

A new report from the Competitive Enterprise Institute suggests activist groups the Campaign for Safe Cosmetics and the Environmental Working Group are unnecessarily scaring consumers and influencing regulations to advance their own “anti-chemical” agendas.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106629

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel